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Protein I is present in all strains of gonococci and is the most abundant outer
membrane protein (1) . Only a limited number of proteins I exist and the type of
protein I expressed by a particular strain is a stable characteristic (2). Therefore,
protein I is used to serotype gonococci (3, 4) . The protein can be surface labeled
with iodine (5, 6) or dansylchloride-cycloheptaamylose (7), demonstrating that it
is partly exposed to the external environment . Antibodies against protein I have
been shown to be bactericidal (8), and there is limited evidence that these
antibodies may protect against salpingitis (9, 10). Recently, it has been shown
(11, 12) that protein I can be translocated from the gonococcal outer membrane
to the plasma membrane of eukaryotic cells . This phenomenon could possibly
trigger endocytosis of gonococci by the host cell . Taken together these data
make protein I a potential vaccine candidate .
Peptide mapping has shown that protein I contains conserved regions as well
as unique sequences (5). These peptide maps could be divided into two groups .
Experiments with proteolytic enzymes have confirmed the existence of two
structurally different proteins I (13) . Protein IA molecules have only one of their
termini exposed to the environment, and show a limited susceptibility to prote-
olysis . Protein IB molecules have both termini buried in the membrane . The
central region of protein IB is exposed and is susceptible to proteolysis by several
enzymes (13-16) . The same degradation pattern is observed, whether intact
gonococci, isolated outer membranes, or purified proteins I are treated with
these enzymes (14) . On the basis of these observations a preliminary model for
the structure of protein IB has been suggested (15, 16) .
Only antibodies against epitopes located in the surface exposed part of protein
I can be expected to contribute to protection against infection . Therefore, we
have tried to define this region of protein IB more precisely and have studied its
antigenic and immunogenic properties . We have fragmented protein IB by
treatment with cyanogen bromide and have isolated the resulting peptides . The
order of these peptides in the intact protein I was determined . Furthermore,
experiments were performed to locate the position of the proteolytic cleavage
sites relative to the cyanogen bromide cleavage sites . The reactivity of these
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peptides with antisera raised against purified protein I and against outer mem-
brane complexes was determined.
The surface-exposed part of protein IB probably carries the serotype-specific
determinants. It is not clear whether apart from these epitopes, common epitopes
also reside in this region . To address this question we have raised antisera against
surface-exposed peptides and studied the reactivity of these sera with heterolo-
gous outer membranes.
Materials and Methods
Gonococcal Strains and Growth Conditions.
￿
The following gonococcal strains were used
(serotypes within parenthesis): B2(1), 8658(2), 7929(3), 6611(4), C3(5), 8035(6),
5766N(7), F62(8), and F6(9). Bacteria were cultivated at 35°C in Frantz medium (17),
supplemented with 0.2% yeast extract dialysate and 0.2% Casamino acids (Technical;
Difco Laboratories Inc., Detroit, MI) in a 40-liter fermentor. The pH was maintained at
7.0, and p02 at 10%. Cultures were inactivated by heating at 56 °C for 30 min. After
centrifugation the bacteria were pooled and lyophilized. Outer membrane complexes
(OMC)' were isolated from the cell-free culture supernatant as described before (18).
Purification of Protein I.
￿
Strain C3 was used to isolate protein I using the method
described by Blake and Gotschlich (19).
Cyanogen Bromide Cleavage.
￿
Chemical cleavage of protein I at methionine residues
with cyanogen bromide was performed by the method of Gross and Witkop (20). 10 mg
of purified protein I was precipitated by addition of ethanol. The protein pellet was
dissolved in 1 ml of 70% formic acid containing 100 mg of cyanogen bromide (Pierce
Chemical Co., Rockford, IL). After incubation for 20 h at room temperature in the dark,
the reaction mixture was dried under vacuum in a Speed Vac centrifuge (Savant Instru-
ments, Hicksville, NY). The pellet was resuspended in water and dried again to remove
traces ofcyanogen bromide and formic acid.
SDS-PAGE.
￿
Samples were dissolved in 8 M urea and then diluted with an equal volume
of sample buffer containing 0.125 M Tris-HCl (pH 6.8), 4% DTT, 20% glycerol, and
0.004% bromophenol blue. Samples were heated for 5 min at 100°C. Electrophoresis was
performed on 2.5-mm gels by a modification of the method of Laemmli (21). The running
gel contained 15% acrylamide, 0.75% bisacrylamide, and 4 M urea. The stacking gel
contained 5% acrylamide and 0.13% bisacrylamide. A cyanogen bromide digest from
myoglobin was used as molecular weight standard (Pharmacia Fine Chemicals, Uppsala,
Sweden).
Two-Dimensional Peptide Mapping.
￿
A modification of the peptide mapping technique
described by Pepinsky was used (22). 1 mg of protein I was partly degraded with cyanogen
bromide (2 mg) for 30 min at room temperature. The reaction mixture was dried and
dissolved in SDS-PAGE sample buffer. After electrophoresis, the gel was briefly stained
with Coomassie brilliant blue and a longitudinal strip containing the separated fragments
was excised. The entire gel strip was then incubated in a solution of 100 mg/mlcyanogen
bromide in 0.1 M HCI. The cyanogen bromide was diluted from a stock solution of 600
mg/ml in 70% formic acid. After I h at room temperature the gel strip was washed four
times for 15 min with 0.05 M Tris, pH 8 .8, to remove unreacted cyanogen bromide.
After a 10-min incubation in SDS-PAGE sample buffer at 60°C, the gel strip was placed
on top of a second SDS-urea polyacrylamide gel, and electrophoresis was performed at
right angles to the first dimension run. After electrophoresis the peptide spots were
visualized by silver staining (23).
Enzymatic Digestion.
￿
Carboxypeptidase Y (Pierce Chemical Co.) was dissolved in 0 .1 M
sodium citrate buffer, pH 5.3. Tosylamino-2-phenylethyl chloromethyl ketone (TPCK)-
treated trypsin and chymotrypsin (Worthington Biochemical Corp., Freehold, NJ) were
dissolved in I mM HCl. Stock solutions were kept frozen before use. Proteolysis was
performed by addition of enzyme to the purified protein I preparation (enzyme/substrate
'Abbreviation used in this paper:
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ratio of 1 :100): In the case of carboxypeptidase Y, the solution was diluted with an equal
volume of 0.1 M sodium citrate buffer, pH 5 .3 . Incubation was carried out at 37°C for 2
h. Degraded protein was precipitated by additional of ethanol to a final concentration of
80%. The samples were then processed for SDS-PAGE or degraded with cyanogen
bromide as described.
Isolation ofPeptides.
￿
For preparative purposes gels were loaded with 150 Ag/track of
cyanogen bromide digestion mixture. After electrophoresis the gels were briefly stained
with Coomassie brilliant blue to locate the peptide bands. These were excised, washed
with water, and subsequently minced with a spatula. An equalvolume of extraction buffer
(8 M urea, 0.25 M Tris [pH 8.8], 1 % (wt/vol) SDS) was added and the slurry was incubated
for 10 min at 50°C. After centrifugation the supernatant was collected and the extraction
procedure was repeated three more times. The combined supernatants were filtered
through a 0.22-,m filter to remove residual gel particles. SDS and urea were removed by
precipitating the peptides with 90% aceton. Purity of peptides was checked by analytical
SDS-PAGE.
Preparation of Antisera.
￿
Groups of eight random-bred mice (strain Cpb:SE) were
immunized intraperitoneally. Protein I was denatured by addition of excess SDS and
boiling for 5 min . OMC, native protein I, and denatured protein I were adsorbed to a
100-fold excess of AIP04 and used in a 1-,ug dose. Cyanogen bromide peptides were
suspended in 0.15 M NaCl, emulsified with an equal volume of CFA, and injected in a
10-lig dose. Booster injections were administered after 6 wk using the same dose and
route. 2 wk later the mice were bled. Sera were pooled and stored at -20°C.
Absorption ofAntisera.
￿
To free antisera from antibodies capable of reacting with the
native outer membrane, sera were absorbed with OMC. The sera were diluted 1 :100 with
0.9% NaCl and incubated with OMC at several concentrations (see Results). After 1 h at
37°C and 16 h at 4°C the OMC were removed by centrifugation (1 h at 300,000 g). The
supernatants were tested by ELISA and immunoblotting.
Enzyme-linked Immunosorbent Assay (ELISA).
￿
Polyvinylchloride microtiter plates were
coated overnight at room temperature. OMC were coated at a concentration of 5,ug/ml
in PBS. Purified peptides were dissolved in a small volume of 8 M urea and subsequently
diluted in 50 mM sodium carbonate buffer (pH 9.6) to a protein concentration of 0.5-
1 .0 1Lg/ml. The final urea concentration was <10 mM. Afterwashing with PBS containing
0 .02% Tween-80, remaining adsorption sites were blocked by a 1-h incubationwith 0.5%
BSA in PBS. The plates were subsequently incubated for 1 h each with serum and goat
anti-mouse IgG conjugated to horseradish peroxidase. The sera were diluted with washing
buffer containing 0 .5% BSA. 3,3',5,5'-tetramethylbenzidine (Sigma Chemical Co., St.
Louis, MO) was used as substrate. OD450 was determined on an Titertek Multiscan
immunoassay reader (Flow Laboratories, Inc., McLean, VA).
Immunoblotting.
￿
Cyanogen bromide-digested protein I was subjected to SDS-PAGE
(1 Ag of protein per track). The peptides were transferred to nitrocellulose using the
Western blotting technique of Burnette (24) with the buffer system described by Towbin
(25). Electrophoretic transfer was performed for 2 h at 500 mA. After transfer, the
nitrocellulose was cut into strips that were washed overnight in PBS with 0.5% Tween-80
(washing buffer). The strips were then incubated for 60 min with mouse antisera diluted
in washing buffer containing 0.5% (wt/vol) BSA. Usually a 1 :500 dilution was used. After
washing for 60 min the strips were incubated with peroxidase-conjugated goat anti-mouse
IgG (diluted 1 :1,000 in the BSA-containing washing buffer). The nitrocellulose strips
were then washed again for 60 min. The strips were developed with a dioctylsulfosuccinate-
tetramethylbenzidine substrate (26).
Analytical Methods.
￿
Protein was determined by a modification of the method of Lowry
et al. (27) as described by Peterson (28). Alternatively, a commercial protein assay kit
(Pierce Chemical Company) was used (29). BSA was used as standard.
Results
Ordering of the Cyanogen Bromide Fragments of Protein I.
￿
When protein IB
(strain C3, serotype 5) was treated with cyanogen bromide five fragments were66
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FIGURE 1 .
￿
SDS-PAGE analysis of cyanogen bromide-degraded pro-
tein I . Protein I was degraded with a 10-fold excess of cyanogen
bromide . Samples were taken after 0 min (A), 10 min (B), 30 min (C),
and 24 h (D) .
produced . These fragments were resolved by SDS-urea polyacrylamide gel
electrophoresis as shown in Fig . 1 . The gel system used allows the separation of
peptides with a molecular weight down to ^-2,000 . Therefore, all major frag-
ments are detected in this way . When the cyanogen bromide concentration or
reaction time were increased theintensityof theupper twofragments diminished,
with a concomitant increase in intensity of the three smaller peptides, but no
additional fragments were generated . The three lower peptides, having Mr of
8,000, ^-13,000, and ^-15,000, are therefore final cleavage products . The
upper two fragments result from incomplete cleavage of protein 1 . We have used
the incomplete cleavage products to deduce the order of the peptides in the
intact protein I . To this end, protein I was treated with a limited amount of
cyanogen bromide to assure the presence of a substantial amount of incomplete
cleavage products in the reaction mixture . After separation of the peptides by
SDS-PAGE as in Fig. 1, an entire longitudinal gel strip was excised and treated
with a high concentration of cyanogen bromide to further cleave the interme-
diary products . The entire gel strip was then placed on top ofa second SDS-urea
slab gel and electrophoresis was performed at right angles to the first dimension
run . Fig. 2 shows the resulting pattern of peptide spots . Complete cleavage
products resist cleavage in the second cyanogen bromide incubation and there-
fore yield a single spot on the diagonal . Partial cleavage products are degraded
further and yield more spots. The three peptides of low molecular weight were
found to be resistant to the second cleavage and therefore are final cleavage
products . One of the incomplete cleavage products was split into fragments of
8,000 and 13,000 mol wt, whereas the other one was split into fragments of
8,000 and 15,000 mol wt . From these results we conclude that the 8,000 mol wt
fragment is flanked by both the 13,000 and the 15,000 mol wt fragments and is
consequently in the middle of the intact protein I molecule . Although the three
final products account for the total molecular weight of protein 1, it cannot be
excluded that an additional small peptide (<2,000 mol wt) is generated that is
not detected in our SDS-PAGE system . However, if this were the case we would
expect to see additional intermediary products appearing as doublets on the gel .
As no doublets were visible this implies that additional peptides are either very
small (i.e ., smaller than five amino acids) or absent .
To determine which of the larger peptides is derived from the NH2-terminus,
protein I was first treated with carboxypeptidase Y and subsequently with
cyanogen bromide. The SDS-PAGE profile of the resulting peptides revealedcleaved at
with the
I is tre
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peptides from protein I by two-dimensional
etectrophoretic analysis. Protein I was de-
graded with a twofold excess of cyanogen bro-
mide for 30 min and the resulting peptides
were separated by SDS-PAGE and silver
stained . A duplicate gel strip was treated with
100 mg/ml cyanogen bromide and the result-
'
￿
fragments were electrophoresed into an
slab get . Peptide spotswere visualized
' ' (A) Undegraded protein 1 ; (B
intermediate cleavageproducts; and (D-
complete cleavage products .
FIGURE 3.
￿
SDS-PAGE analysis o£ a combined proteoly
ical cleavage ofprotein 1 . The following combinations were used: (A)
trypsin followed by cyanogen bromide; (B) chymotrypsin followed by
cyanogen bromide ; (C) cyanogen bromide. Native protein I was treated
with the indicated enzyme. After precipitation the product was de-
graded with cyanogen bromide.
that the 15,000 mol wt peptide was shifted to a lower molecular weight .
Therefore, this peptide forms the COON-terminal part of protein I and the
13,000 mol wt peptide is derived from the NI-I2-terminus .
Location of the Sites Susceptible to Proteolysis.
￿
It has been observed (15) that
when outer membranes are treated with trypsin or chymotrypsin, protein I is
ited number of sites, yielding two products that remain associated
mbrane .Thesame cleavage pattern is observed when purified protein
with these enzymes . Apparently the detergent micelles take over the
membrane phospholipids in shielding large partsof the protein
andprotecting it against proteolysis.We have determined thecyanogen bromide
peptides that contain these cleavage sites by a combination of enzymatic and
chemical degradation of protein I. Protein I was first treated with either trypsin
or chymotrypsin . Then the product was further degraded by treatment with
cyanogen bromide. Fig . 3 shows the resulting fragmentation patterns . When
cyanogen bromide treatment was preceded by an incubation with trypsin, both
15,000 and 13,000 mot wt fragments remained unaltered, but the 8,000 mol wt68
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FIGURE 4 .
￿
Preliminary peptide map of protein
III . The cleavage sites for trypsin, chymotrypsin,
and cyanogen bromide are indicated with arrows .
The peptides obtained after cyanogen bromide
degradation are numbered CBI to CB3, starting
from the NH2-terminus .
FIGURE 5.
￿
SDS-PAGE analysis of purified cyanogen bromide pep-
tides from protein I . Protein I was degraded with a 10-fold excess of
cyanogen bromide for 24 h and the resulting peptides were separated
on a preparative SDS-urea slab gel. Peptide bands were excised and
extractedas described in Materialsand Methods . Purity ofthe peptides
was assessed by analytical SDS-PAGE . (A)CB3, (B) CBI, and(C) CB2 .
fragment was replaced by a peptide having a molecular weight of ^-6,000 .
Apparently, the 8,000 mol wt fragment contains the tryptic cleavage site . When
chymotrypsin was used instead of trypsin, all three peptides remained unaltered .
Therefore, the chymotryptic cleavage site is located at or very near to one of the
cyanogen bromide cleavage sites . From the fact that the largest intermediary
product of 23,000 mol wtwas very much reduced in intensity, it can be concluded
that this site is located between the 15,000 and the 8,000 mol wt fragment .
Fig . 4 schematically summarizes the information obtained from these experi-
ments . The cyanogen bromide peptides are numbered CBI, CB2, and CB3,
starting from the NH2-terminus . The proteolytic cleavage sites are located in
CB2 and close to thejunction between CB2 and CB3 . We therefore assume that
this region is part of the hydrophilic loop of protein I that protrudes from the
membrane .
Purification of Peptides.
￿
To study the antigenic properties of the cyanogen
bromide peptides by ELISA, we have attempted to purify the individual peptides .
A major problem during the purification was the very hydrophobic nature of
both CB1 and CB3, causingthem to coelute in various chromatographic systems .
Reverse-phase chromatography in the presence of 60% formic acid resulted in
the isolation ofCB2 in pure form, but both other peptides were eluted together .
In view of these problems we decided to isolate the peptides by preparative SDS-
PAGE . The peptides were extracted from the gels with a buffer containing 8 M
urea and 1 % SDS (see Fig . 5) .
Antigenic Activity of the Cyanogen Bromide Fragments.
￿
After removal of urea
and SDS by aceton precipitation, the peptides were used to coat microtiter plates
for ELISA . Fig. 6 shows the reaction of a number of antisera with the three
peptides . It can be seen that antiserum raised against purified protein I reactedc
0
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FIGURE 6.
￿
ELISA titration curves of several sera. Micratiter plates were coated with CB1
(A), CB2 (B), and CB3 (C) . The following sera were tested : anti-OMC (triangles), anti-native
PI (circles), and anti-SDS-denatured PI (squares).
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FIGURE 7.
￿
Western blot analysis ofsera raised against SDS-denatured
protein I (A) and native protein I (B). Note the strong reaction with
CBI andthevery weak reaction withCB2 inAas compared withB.
well with all three peptides, whereas anti-SDS-denatured protein I reacted
strongly with CBI but only moderately with the other peptides . Antisera against
theoutermembranecomplex reactedwith all three peptides, showinga relatively
strong reaction with CB2. Probably this region of protein I is very immunogenic
when present in the outer membrane .
We have also used the immunoblotting technique to detect the presence of
antibodies against the three peptides in the aforementioned antisera . The results
are shown in Fig . 7 . Antiserum against purified protein I reacted with all three
cyanogen bromide peptides . On the other hand, an antiserum raised against
SDS-denatured protein I reacted very strongly with CB I and displayed only a
moderate reaction with both other peptides . ApparentlyCB I contains an epitope
that becomes immunodominant once the protein is denatured with SDS. These
results clearly confirm the ELISA results .70
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Absorption ofantibodies against the cyanogen bromide peptides from protein I
by native outer membranes . Antiserum against native protein I was incubated with various
amounts of OMC. After incubation, residual antibodies against CBI (left), CB2 (middle), and
CB3 (right), were determined by ELISA .
tern blot analysis of antiserum raised against native
protein I before (A)and after (B) absorption with homologous OMCs .
Now that antibodies against CB3 are partly absorbed and antibodies against CB2 am completely absorbed .
These experimentsdemonstrated the presence of antibodies against individual
peptides in sera raised against purified protein 1. To determine whether these
antibodies could also react with protein I present in the outer membrane,
absorption experiments were performed . Antiserum raised against protein I was
first absorbed with homologous OMC and then the residual antibodies against
were determined by ELIS
￿
(Fig. 8) . Antibodies against CB2
absorbed by the OMC, in accordance with its surface-exposed
ies against CB3 were also absorbed, although much higher
required . Anti-CBI antibodies were not absorbed
peptide is not exposed at the membrane surface.
bed antiserum was also analyzed by immunoblotting . Fig . 9 shows t]
against purified protein I was absorbed, the antibodies reactin
CB2 were completely removed. Reaction with CB3 was very much reducTABLE I
Ability ofAntiserum Raised against CB2 (Serotype 5) to React with
Heterologous OuterMembranes as Determined by ELISA
* OD45o at a serum dilution of 1:400 .
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FIGURE 10 .
￿
Western blot analysis of antisera raised against puri-
fied cyanogen bromide peptides from protein I . (A) anti-CB3 ; (B)
anti-CB1 ; (C) anti-CB2 .
but the reaction with CBI was hardly diminished . These results show that when
purified protein I is used to generate an antiserum, antibodies against epitopes
residing in CB2 and CB3 are induced that can also react with the native outer
membrane . Antibodies against CBI do not react with the outer membrane .
Probably this fragment of protein I is buried in the membrane and is therefore
not available for reaction with antibodies .
We have also determined the presence of antibodies against the cyanogen
bromide peptides in antisera that were raised against OMCs of heterologous
gonococcal strains . These sera contained only very low amounts of antibodies
reacting with the serotype 5 cyanogen bromide peptides . Apparently, mainly
serotype-specific antibodies are induced after immunization with outer mem-
branes .
Immunogenic Activity ofCB2 .
￿
Antisera raised against heterologous OMC con-
tained only very low amounts of antibodies against the serotype 5 CB2 peptide .
This could mean that the surface-exposed part of protein III contains only
serotype-specific epitopes . Another possibility is that common epitopes do exist
but are not immunogenic when OMC are used as immunogen . To investigate
these possibilities we raised an antiserum against the isolated CB2 fragment and
tried to determine the presence of crossreactive antibodies in this serum . Fig . 10
shows an immunoblotting experiment using sera raised against the three cyano-
gen bromide peptides . It can be seen that the sera react only with the peptides
Serotype OMC ELISA reading*
1 0.26
2 0.18
3 0.20
4 0.92
5 1 .05
6 1 .75
7 0.50
8 0.12
9 0.0672
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used for immunization and with the intermediary products containing these
peptides. We were able to show that the serum against CB2 reacted with the
homologous native outer membrane . Table I shows the reaction of this serum
with heterologous OMC as determined by ELISA. It can be seen that the serum
reacted strongly with OMC of serotypes 4, 5, 6, and 7. Therefore, proteins IB
ofthese serotypes share at least one epitope that is surface exposed.
Discussion
It has been shown (15) before that when intact gonococci or isolated outer
membranes are treated with proteolytic enzymes, protein I is cleaved into two
fragments that remain associated with the membrane. On the basis of this
observation Blake et al. (15, 16) have suggested that protein I has a looplike
structure with both termini buried in the membrane and the central part of the
protein exposed to the environment. This model was suggested for protein IB,
present in strains of the WII/WIII serogroup. Protein IA, expressed by strains
ofthe WI serogroup has been shown (13) to have one ofits termini exposed on
the surface of the membrane. The aim of this study was to define the surface-
exposed part ofprotein IB in more detail and to determine whether this region
contains conserved epitopes. All experiments were performed with a serotype 5
strain.
We have found that afterdegradation with cyanogen bromide three fragments
are formed, having M,. of 8,000, 13,000 and 15,000 . Using a special peptide-
mapping technique we have determined the order ofthese peptides in the intact
protein I (see Fig. 2). A combination ofproteolytic and chemical degradation of
protein I revealed that the middle peptide (8,000 M,.) contains the site where
trypsin splits the native protein. The cleavage site for chymotrypsin was found
to be located at thejunction between the 15,000 and the 8,000 mol wt fragment
(see Fig. 4). We therefore propose a model for protein I in which the NH2-
terminal part of the 15,000 mol wt fragment and a large part of the 8,000 mol
wt fragment are part of the surface-exposed region.
Antisera were raised against OMCs, purified protein I, and SDS-denatured
protein I. These sera were tested for reactivity with the three cyanogen bromide
peptides by immunoblotting and ELISA. Some interesting quantitative differ-
ences between these sera were observed. Antiserum against the denatured
protein I reacted very strongly with CBI, whereas the other two sera showed
only a moderate reaction with this peptide. Apparently this peptide is not very
immunogenic in the native protein, probably because it is not accessible on the
surface. It may be that it is buried in the tertiary structure of protein I, or that
it is located at the interface between the protein I molecules in the native trimer.
Once the protein is denatured this region becomes immunodominant. It was also
shown that antibodies against CBI cannot react with the native outer membrane
(Fig. 8). This observation isin agreement withCB1 beingburied in the membrane
or in the protein structure. Antibodies against CB2 and CB3 were shown to be
bound by the native outer membrane, confirming their surface-exposed nature.
The fact that relatively large amounts ofantibodies against CB2 are induced by
immunization with OMC also suggests that this peptide is surface exposed.
After immunization with OMC, mainly serotype-specific antibodies areTEERLINK ET AL. 73
formed. Sera raised against heterologous OMC hardly react with the serotype 5
CB2 peptide. Therefore, the surface-exposed part of protein IB contains only
type-specific epitopes, or alternatively, common epitopes are present but are
immunorecessive. We were were able to demonstrate the existence of common
epitopes by immunization with CB2. The serum reacted well with several OMC
within the WII/WIII serogroup (i .e., serotypes 4-7).
Comparison of the immunochemistry of protein I with that of the gonococcal
pilus reveals some interesting similarities. The amino acid sequence of the pilus
has been determined (30) and its immunochemistry has been studied in detail
(31-34). Pili, like protein I, contain both conserved and variable antigenic
determinants. The pilin subunit contains an immunodominant variable region
and a common domain that is hardly immunogenic. Studies with a panel of mAbs
showed that crossreactive antibodies bound to SDS-unfolded pilin, whereas type-
specific antibodies bound significantly less. Therefore, the crossreactive antibod-
ies recognize the conserved primary structure, whereas the type-specific antibod-
ies probably recognize part of the tertiary structure of the variable region (32).
It may be that the antigenic determinants of protein I also fall into two classes:
On the one hand, serotype-specific determinants that are conformation depend-
ent, and on the other hand, common epitopes that are linear. Antibodies against
the conformation-dependent epitopes are induced by immunization with native
protein I or outer membranes. Antibodies against the common epitopes are
more readily induced by immunization with denatured forms of protein I or
isolated peptides. That the variable surface-exposed part of protein I contains a
conserved epitope is not without precedent. Within the variable domain of the
pilin subunit a common epitope was detected with an mAb (33).
Recently, another group has succeeded in raising an mAb against a surface-
exposed common epitope of protein IB (35). This mAb was shown to be
bactericidal and opsonic (36) . The epitope was destroyed by treatment of protein
I with chymotrypsin but not by treatment with trypsin. Although the authors
used another strain (P9), the proteolytic cleavage pattern very much resembles
that of strain C3 used in our study. This would mean that the epitope is located
close to the junction between CB2 and CB3 . Currently, we are raising mAbs
against the individual cyanogen bromide peptides. The availability of a panel of
these mAbs will aid in locating the conserved epitope with more precision.
Summary
Two distinct species of gonococcal porin proteins exist that differ with regard
to surface exposure. Protein IB, expressed by strains of the WII/III serogroup,
has both termini buried in the outer membrane, leaving a central region of the
molecule exposed at the cell surface. We have attempted to define this region of
protein IB in detail by studying the antigenic and immunogenic properties of
peptides derived from protein IB. Treatment of gonococcal protein IB (serotype
5) with cyanogen bromide resulted in cleavage of protein IB into three major
fragments of M,. of 15,000, 13,000, and 8,000. The location of these peptides in
the intact protein was determined by analysis of partial cleavage products. The
8,000 M,. peptide (CB2) was found to be located in the central region of the
protein. Chymotrypsin cleavage of protein IB revealed a cleavage site near one74
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ofthe cyanogen bromide cleavage sites. Trypsin was found to cleave the protein,
either in outer membranes complexes (OMC) or in detergent micelles, in the
central CB2 fragment. These results suggest that CB2 is a part of the surface-
exposed region ofprotein IB.
Immunization ofmice with purified protein IB (serotype 5) induced antibodies
against all three CB-peptides. Absorption of the sera with homologous OMC
resulted in a complete removal of antibodies against CB2, supplying further
evidence for its surface-exposed nature . Antibodies against the 13,000 M,peptide
(CBI) could not be absorbed with intact OMC, suggesting that this peptide is
buried within the outer membrane.
Antisera raised against CB2 of serotype 5 demonstrated a considerable cross-
reactivity with heterologous outer membranes. On the contrary, intact OMC
induced mainly type-specific antibodies. These data demonstrate the presence of
conserved epitopes on the surface-exposed CB2 peptide. These conserved epi-
topes are generally not very immunogenic when present in intact OMC.
Receivedfor publication 3 March 1987.
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